Literature DB >> 31471574

Up-front autologous hematopoietic stem cell transplantation (AHSCT) from a single Brazilian center.

Yara Abrão Vasconcelos Vivas1, Vânia Tietsche de Moraes Hungria2, Luciano José Megale Costa3, Kelli Borges Dos Santos4, Alfredo Chaoubah5, Maria Teresa Bustamante-Teixeira6, Leonardo Peres Vivas7, Angelo Maiolino8, Abrahão Elias Hallack Neto9.   

Abstract

Mesh：

Year:  2019        PMID： 31471574     DOI： 10.1038/s41409-019-0659-1

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  7 in total

1.  Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.

Authors:  Mariano Berro; Jorge A Arbelbide; Maria M Rivas; Ana Lisa Basquiera; Gonzalo Ferini; Adriana Vitriu; Cecilia Foncuberta; Nicolas Fernandez Escobar; Alejandro Requejo; Vera Milovic; Sebastian Yantorno; Milagros Szelagoswki; Juliana Martinez Rolon; Gonzalo Bentolila; Juan Jose Garcia; Pablo Garcia; Gaston Caeiro; Martin Castro; Gregorio Jaimovich; Silvina Palmer; Jose I Trucco; Lucia A Bet; Bronwen E Shaw; Gustavo D Kusminsky
Journal:  Biol Blood Marrow Transplant       Date:  2017-06-29       Impact factor: 5.742

2.  A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

Authors:  M Attal; J L Harousseau; A M Stoppa; J J Sotto; J G Fuzibet; J F Rossi; P Casassus; H Maisonneuve; T Facon; N Ifrah; C Payen; R Bataille
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

3.  Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma.

Authors:  Helgi J K van de Velde; Xiangyang Liu; Gang Chen; Andrew Cakana; William Deraedt; Martine Bayssas
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

4.  Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.

Authors:  Jean-Luc Harousseau; Herve Avet-Loiseau; Michel Attal; Catherine Charbonnel; Frederic Garban; Cyrille Hulin; Mauricette Michallet; Thierry Facon; Laurent Garderet; Gerald Marit; Nicolas Ketterer; Thierry Lamy; Laurent Voillat; Francois Guilhot; Chantal Doyen; Claire Mathiot; Philippe Moreau
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

5.  Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Authors:  Antonio Palumbo; Hervé Avet-Loiseau; Stefania Oliva; Henk M Lokhorst; Hartmut Goldschmidt; Laura Rosinol; Paul Richardson; Simona Caltagirone; Juan José Lahuerta; Thierry Facon; Sara Bringhen; Francesca Gay; Michel Attal; Roberto Passera; Andrew Spencer; Massimo Offidani; Shaji Kumar; Pellegrino Musto; Sagar Lonial; Maria T Petrucci; Robert Z Orlowski; Elena Zamagni; Gareth Morgan; Meletios A Dimopoulos; Brian G M Durie; Kenneth C Anderson; Pieter Sonneveld; Jésus San Miguel; Michele Cavo; S Vincent Rajkumar; Philippe Moreau
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

6.  Thalidomide and hematopoietic-cell transplantation for multiple myeloma.

Authors:  Bart Barlogie; Guido Tricot; Elias Anaissie; John Shaughnessy; Erik Rasmussen; Frits van Rhee; Athanasios Fassas; Maurizio Zangari; Klaus Hollmig; Mauricio Pineda-Roman; Choon Lee; Giampaolo Talamo; Raymond Thertulien; Elias Kiwan; Somashekar Krishna; Michele Fox; John Crowley
Journal:  N Engl J Med       Date:  2006-03-09       Impact factor: 91.245

7.  Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project.

Authors:  Saad Z Usmani; Antje Hoering; Michele Cavo; Jesus San Miguel; Hartmut Goldschimdt; Roman Hajek; Ingemar Turesson; Juan Jose Lahuerta; Michel Attal; Bart Barlogie; Jae Hoon Lee; Shaji Kumar; Stig Lenhoff; Gareth Morgan; S Vincent Rajkumar; Brian G M Durie; Philippe Moreau
Journal:  Blood Cancer J       Date:  2018-11-23       Impact factor: 11.037
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.